QuiVad

Home / Netherlands / Alfen N.V.

Alfen N.V.

Short position disclosed on August 13, 2026.

Follow

Evolution of the disclosed total

0%5%10%15%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 18.97% on September 11, 2024. The shaded band is the year shown above.

March 4, 2020 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
WorldQuant, LLC1.06%+0.65 ptAugust 13, 2026
Citadel Securities (Europe) Limited0.70%+0.29 ptAugust 12, 2026
Millennium Capital Partners LLP0.51%+0.05 ptJuly 22, 2026

On the other side: the funds that hold Alfen N.V. Titelia

History of disclosures

1769 disclosures on record for this share.
DateFund% of capitalEnd of publication
May 8, 2024Qube Research & Technologies Ltd.1.30%still open
May 7, 2024Millennium International Management LP0.95%still open
May 7, 2024Wellington Management International Ltd.0.52%still open
May 6, 2024Qube Research & Technologies Ltd.1.27%still open
May 3, 2024Millennium International Management LP1.08%still open
May 2, 2024Citadel Advisors LLC0.48%still open
April 30, 2024Qube Research & Technologies Ltd.1.11%still open
April 30, 2024Millennium International Management LP1.10%still open
April 30, 2024Voleon Capital Management LP0.93%still open
April 30, 2024Connor, Clark & Lunn Investment Management Ltd.0.61%still open
April 30, 2024Marshall Wace LLP0.59%still open
April 30, 2024Citadel Advisors LLC0.55%still open
April 29, 2024Millennium International Management LP1.33%still open
April 29, 2024PDT Partners, LLC1.15%still open
April 29, 2024Qube Research & Technologies Ltd.0.99%still open
April 29, 2024Marshall Wace LLP0.64%still open
April 29, 2024Citadel Securities (Europe) Limited0.48%still open
April 29, 2024Citadel Advisors LLC0.43%still open
April 26, 2024Qube Research & Technologies Ltd.0.73%still open
April 26, 2024Citadel Advisors LLC0.59%still open
April 26, 2024Citadel Securities (Europe) Limited0.50%still open
April 25, 2024Qube Research & Technologies Ltd.0.84%still open
April 25, 2024Citadel Advisors LLC0.60%still open
April 25, 2024Citadel Securities (Europe) Limited0.60%still open
April 24, 2024Citadel Securities (Europe) Limited0.59%still open
April 24, 2024Systematica Investments Limited0.50%still open
April 23, 2024Qube Research & Technologies Ltd.0.78%still open
April 23, 2024Citadel Securities (Europe) Limited0.60%still open
April 23, 2024Citadel Advisors LLC0.51%still open
April 22, 2024Millennium International Management LP1.68%still open
April 19, 2024Millennium International Management LP1.75%still open
April 19, 2024Qube Research & Technologies Ltd.0.87%still open
April 19, 2024Marshall Wace LLP0.71%still open
April 19, 2024Citadel Securities (Europe) Limited0.53%still open
April 18, 2024Millennium International Management LP1.80%still open
April 18, 2024PDT Partners, LLC1.01%still open
April 18, 2024Qube Research & Technologies Ltd.0.95%still open
April 18, 2024Jupiter Investment Management Limited0.49%still open
April 17, 2024Millennium International Management LP1.75%still open
April 17, 2024Qube Research & Technologies Ltd.1.01%still open
April 17, 2024PDT Partners, LLC0.95%still open
April 17, 2024Voleon Capital Management LP0.87%still open
April 17, 2024Marshall Wace LLP0.60%still open
April 17, 2024Connor, Clark & Lunn Investment Management Ltd.0.54%still open
April 17, 2024Wellington Management International Ltd.0.48%still open
April 17, 2024Citadel Advisors LLC0.46%still open
April 17, 2024Canada Pension Plan Investment Board0.45%still open
April 16, 2024Qube Research & Technologies Ltd.1.25%still open
April 16, 2024PDT Partners, LLC1.00%still open
April 16, 2024Citadel Advisors LLC0.67%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Alfen N.V., source AFM, data as at August 13, 2026, https://www.quivad.com/action/alfen-n-v?page=22